Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLOOM: LPCN 1154A in Postpartum Depression
NCT07822321Phase 3Recruiting
- Sponsor
- Lipocine Inc
- Start
- Sep 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postpartum depression (PPD) comparing LPCN 1154A Tablets with Placebo Tablets (2 arms). Primary endpoint: Hamilton Depression Rating Scale 17-item total score. Started Sep 2026; status: recruiting.
02
Drugs
brexanolone
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT07822321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07822321.